Global New Medical Materials and Biomaterials 麻豆原创 Research Report 2025

Publication ID:

PB504253395

Publication Date:

April 29, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for New Medical Materials and Biomaterials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
In US, New Medical Materials and Biomaterials key players include STR, Avitus, Sagemax, Stratasys, Formlab, etc.
In terms of product, Bioceramics is the largest segment, with a share over 20%. And in terms of application, the largest application is Catheters, followed by Dental Products, Transplant Components, etc.
This report aims to provide a comprehensive presentation of the global market for New Medical Materials and Biomaterials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Medical Materials and Biomaterials.
The New Medical Materials and Biomaterials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Medical Materials and Biomaterials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New Medical Materials and Biomaterials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
STR
Avitus
Sagemax
Stratasys
Formlab
NanoH2O (LG)
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
Invibio
Secant Medical
TeraPore Technologies
Segment by Type
Medical Polymers
Bioceramics
Medical 3D Printing Materials
Membranes
Surface Modifications
Others
Segment by Application
Packaging
Transplant Components
Dental Products
Catheters
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of New Medical Materials and Biomaterials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global New Medical Materials and Biomaterials 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medical Polymers
1.2.3 Bioceramics
1.2.4 Medical 3D Printing Materials
1.2.5 Membranes
1.2.6 Surface Modifications
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global New Medical Materials and Biomaterials 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Packaging
1.3.3 Transplant Components
1.3.4 Dental Products
1.3.5 Catheters
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Medical Materials and Biomaterials 麻豆原创 Perspective (2020-2031)
2.2 Global New Medical Materials and Biomaterials Growth Trends by Region
2.2.1 Global New Medical Materials and Biomaterials 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 New Medical Materials and Biomaterials Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 New Medical Materials and Biomaterials Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 New Medical Materials and Biomaterials 麻豆原创 Dynamics
2.3.1 New Medical Materials and Biomaterials Industry Trends
2.3.2 New Medical Materials and Biomaterials 麻豆原创 Drivers
2.3.3 New Medical Materials and Biomaterials 麻豆原创 Challenges
2.3.4 New Medical Materials and Biomaterials 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Medical Materials and Biomaterials Players by Revenue
3.1.1 Global Top New Medical Materials and Biomaterials Players by Revenue (2020-2025)
3.1.2 Global New Medical Materials and Biomaterials Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global New Medical Materials and Biomaterials 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by New Medical Materials and Biomaterials Revenue
3.4 Global New Medical Materials and Biomaterials 麻豆原创 Concentration Ratio
3.4.1 Global New Medical Materials and Biomaterials 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Medical Materials and Biomaterials Revenue in 2024
3.5 Global Key Players of New Medical Materials and Biomaterials Head office and Area Served
3.6 Global Key Players of New Medical Materials and Biomaterials, Product and Application
3.7 Global Key Players of New Medical Materials and Biomaterials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 New Medical Materials and Biomaterials Breakdown Data by Type
4.1 Global New Medical Materials and Biomaterials Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global New Medical Materials and Biomaterials Forecasted 麻豆原创 Size by Type (2026-2031)
5 New Medical Materials and Biomaterials Breakdown Data by Application
5.1 Global New Medical Materials and Biomaterials Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global New Medical Materials and Biomaterials Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America New Medical Materials and Biomaterials 麻豆原创 Size (2020-2031)
6.2 North America New Medical Materials and Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America New Medical Materials and Biomaterials 麻豆原创 Size by Country (2020-2025)
6.4 North America New Medical Materials and Biomaterials 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Medical Materials and Biomaterials 麻豆原创 Size (2020-2031)
7.2 Europe New Medical Materials and Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe New Medical Materials and Biomaterials 麻豆原创 Size by Country (2020-2025)
7.4 Europe New Medical Materials and Biomaterials 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Medical Materials and Biomaterials 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific New Medical Materials and Biomaterials 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific New Medical Materials and Biomaterials 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific New Medical Materials and Biomaterials 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Medical Materials and Biomaterials 麻豆原创 Size (2020-2031)
9.2 Latin America New Medical Materials and Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America New Medical Materials and Biomaterials 麻豆原创 Size by Country (2020-2025)
9.4 Latin America New Medical Materials and Biomaterials 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Medical Materials and Biomaterials 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa New Medical Materials and Biomaterials 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa New Medical Materials and Biomaterials 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa New Medical Materials and Biomaterials 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 STR
11.1.1 STR Company Details
11.1.2 STR Business Overview
11.1.3 STR New Medical Materials and Biomaterials Introduction
11.1.4 STR Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.1.5 STR Recent Development
11.2 Avitus
11.2.1 Avitus Company Details
11.2.2 Avitus Business Overview
11.2.3 Avitus New Medical Materials and Biomaterials Introduction
11.2.4 Avitus Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.2.5 Avitus Recent Development
11.3 Sagemax
11.3.1 Sagemax Company Details
11.3.2 Sagemax Business Overview
11.3.3 Sagemax New Medical Materials and Biomaterials Introduction
11.3.4 Sagemax Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.3.5 Sagemax Recent Development
11.4 Stratasys
11.4.1 Stratasys Company Details
11.4.2 Stratasys Business Overview
11.4.3 Stratasys New Medical Materials and Biomaterials Introduction
11.4.4 Stratasys Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.4.5 Stratasys Recent Development
11.5 Formlab
11.5.1 Formlab Company Details
11.5.2 Formlab Business Overview
11.5.3 Formlab New Medical Materials and Biomaterials Introduction
11.5.4 Formlab Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.5.5 Formlab Recent Development
11.6 NanoH2O (LG)
11.6.1 NanoH2O (LG) Company Details
11.6.2 NanoH2O (LG) Business Overview
11.6.3 NanoH2O (LG) New Medical Materials and Biomaterials Introduction
11.6.4 NanoH2O (LG) Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.6.5 NanoH2O (LG) Recent Development
11.7 Covalent-coating
11.7.1 Covalent-coating Company Details
11.7.2 Covalent-coating Business Overview
11.7.3 Covalent-coating New Medical Materials and Biomaterials Introduction
11.7.4 Covalent-coating Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.7.5 Covalent-coating Recent Development
11.8 Nasseo
11.8.1 Nasseo Company Details
11.8.2 Nasseo Business Overview
11.8.3 Nasseo New Medical Materials and Biomaterials Introduction
11.8.4 Nasseo Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.8.5 Nasseo Recent Development
11.9 TriboFilm
11.9.1 TriboFilm Company Details
11.9.2 TriboFilm Business Overview
11.9.3 TriboFilm New Medical Materials and Biomaterials Introduction
11.9.4 TriboFilm Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.9.5 TriboFilm Recent Development
11.10 ACS material
11.10.1 ACS material Company Details
11.10.2 ACS material Business Overview
11.10.3 ACS material New Medical Materials and Biomaterials Introduction
11.10.4 ACS material Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.10.5 ACS material Recent Development
11.11 Palmaz Scientific
11.11.1 Palmaz Scientific Company Details
11.11.2 Palmaz Scientific Business Overview
11.11.3 Palmaz Scientific New Medical Materials and Biomaterials Introduction
11.11.4 Palmaz Scientific Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.11.5 Palmaz Scientific Recent Development
11.12 Invibio
11.12.1 Invibio Company Details
11.12.2 Invibio Business Overview
11.12.3 Invibio New Medical Materials and Biomaterials Introduction
11.12.4 Invibio Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.12.5 Invibio Recent Development
11.13 Secant Medical
11.13.1 Secant Medical Company Details
11.13.2 Secant Medical Business Overview
11.13.3 Secant Medical New Medical Materials and Biomaterials Introduction
11.13.4 Secant Medical Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.13.5 Secant Medical Recent Development
11.14 TeraPore Technologies
11.14.1 TeraPore Technologies Company Details
11.14.2 TeraPore Technologies Business Overview
11.14.3 TeraPore Technologies New Medical Materials and Biomaterials Introduction
11.14.4 TeraPore Technologies Revenue in New Medical Materials and Biomaterials Business (2020-2025)
11.14.5 TeraPore Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

STR
Avitus
Sagemax
Stratasys
Formlab
NanoH2O (LG)
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
Invibio
Secant Medical
TeraPore Technologies

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.